Your browser is no longer supported. Please, upgrade your browser.
Settings
RMD ResMed Inc. daily Stock Chart
RMD [NYSE]
ResMed Inc.
Index- P/E21.24 EPS (ttm)2.47 Insider Own0.80% Shs Outstand140.52M Perf Week-0.06%
Market Cap7.37B Forward P/E17.91 EPS next Y2.93 Insider Trans-22.90% Shs Float138.86M Perf Month-5.99%
Income352.90M PEG2.12 EPS next Q0.59 Inst Own54.90% Short Float8.41% Perf Quarter-11.10%
Sales1.68B P/S4.39 EPS this Y3.30% Inst Trans1.19% Short Ratio13.55 Perf Half Y-18.13%
Book/sh11.27 P/B4.66 EPS next Y10.73% ROA19.20% Target Price59.53 Perf Year1.15%
Cash/sh5.10 P/C10.28 EPS next 5Y10.04% ROE27.40% 52W Range44.83 - 74.55 Perf YTD-5.01%
Dividend1.20 P/FCF47.91 EPS past 5Y15.00% ROI17.30% 52W High-30.22% Beta0.65
Dividend %2.29% Quick Ratio4.50 Sales past 5Y9.00% Gross Margin60.20% 52W Low16.05% ATR1.37
Employees4340 Current Ratio5.40 Sales Q/Q9.10% Oper. Margin24.40% RSI (14)41.52 Volatility2.97% 2.44%
OptionableYes Debt/Eq0.19 EPS Q/Q0.00% Profit Margin26.00% Rel Volume0.51 Prev Close52.47
ShortableYes LT Debt/Eq0.19 EarningsJul 30 AMC Payout36.10% Avg Volume861.75K Price52.02
Recom2.60 SMA20-3.42% SMA50-5.93% SMA200-13.22% Volume406,352 Change-0.86%
Jul-13-15Downgrade Macquarie Neutral → Underperform
Jun-25-15Initiated Barclays Equal Weight $61
May-14-15Reiterated Needham Buy $77 → $65
May-13-15Downgrade BofA/Merrill Buy → Neutral
Apr-27-15Downgrade Goldman Buy → Neutral
Apr-24-15Downgrade Macquarie Outperform → Neutral
Jan-27-15Reiterated Northland Capital Under Perform $40 → $44
Jan-23-15Upgrade Needham Hold → Buy
Jan-23-15Reiterated Canaccord Genuity Hold $42 → $50
May-27-14Downgrade Northland Capital Market Perform → Under Perform
Jan-24-14Reiterated Canaccord Genuity Hold $49 → $43
Oct-08-13Initiated Northland Capital Market Perform $44
Jul-16-13Initiated Needham Hold
Mar-07-13Reiterated Mizuho Neutral $45 → $42
Jan-25-13Reiterated Mizuho Neutral $41 → $45
Oct-26-12Reiterated Mizuho Neutral $39 → $41
Oct-22-12Reiterated Mizuho Neutral $33 → $39
Aug-06-12Reiterated Feltl & Co. Hold $35.75 → $40
Jul-19-12Downgrade Feltl & Co. Buy → Hold $38 → $35.75
Apr-27-12Upgrade Feltl & Co. Hold → Buy $38
Aug-27-15 09:27AM  ResMed, Inc. Earnings Q4, 2015
Aug-20-15 02:45PM  ResMed: Strong on Q4, SERVE-HF Trial Results Pose Concern
Aug-14-15 01:04PM  RESMED INC Financials
Aug-10-15 08:13PM  10-K for ResMed, Inc. at Company Spotlight
Aug-07-15 07:30AM  RESMED INC Files SEC form 10-K, Annual Report
Jul-31-15 10:24AM  ResMed Tops Q4 Earnings Estimates; Hikes Dividend - Analyst Blog
03:22AM  Health sector drives market higher Other
12:57AM  ResMed makes China acquisition Other
Jul-30-15 07:43PM  Edited Transcript of RMD earnings conference call or presentation 30-Jul-15 8:30pm GMT
07:18PM  Resmed records small profit lift Other
06:57PM  ResMed tops Street 4Q forecasts
04:30PM  ResMed Inc Earnings Call scheduled for 4:30 pm ET today
04:07PM  RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and
04:05PM  ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 PR Newswire
04:02PM  ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical PR Newswire
07:07AM  Q4 2015 ResMed Inc Earnings Release - After Market Close
Jul-28-15 12:20PM  ResMed (RMD) Prepares for Q4 Earnings: What to Expect? - Analyst Blog
Jul-13-15 11:24AM  ResMed downgraded by Macquarie
Jul-09-15 02:50PM  ResMed (RMD) Buys CareTouch to Expand in HME Industry - Analyst Blog Zacks
Jul-08-15 09:00AM  ResMed Acquires CareTouch, a Leader in Resupply Solutions for the Home Medical Equipment Industry PR Newswire
Jul-02-15 04:30PM  ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results PR Newswire
Jun-25-15 09:48AM  ResMed (RMD) Stock Coverage Initiated at Barclays at TheStreet
08:22AM  Leader In The 'Growing' Sleep-Disordered Breathing Market Might Be Worth An Investment Benzinga
Jun-19-15 02:15PM  Dump ResMed (RMD) from Your Portfolio Now: Here's Why - Analyst Blog Zacks
09:30AM  New Strong Sell Stocks for June 19th - Tale of the Tape
Jun-12-15 02:35PM  ResMed's S+ Sleep Solution Shows Improved SDB Outcome - Analyst Blog Other
Jun-11-15 09:36PM  Edited Transcript of RMD presentation 10-Jun-15 8:20pm GMT Thomson Reuters StreetEvents
Jun-10-15 04:05PM  The Results Are In: S+ by ResMed Users See Improvement in The Amount and Quality of Their Sleep PR Newswire
Jun-05-15 12:01AM  7 Top Australian Stocks to Buy Now at Barrons.com
May-14-15 11:18PM  The week in numbers to May 15 Other
03:06AM  Resmed punished on sleep trial failure Other
May-13-15 09:52PM  Resmed plunges on sleep therapy fears Other -15.13%
12:15PM  Stocks Fade At Midday; Cal-Maine Jumps To New High at Investor's Business Daily
11:38AM  ResMed (RMD) Stock Falls After Sleep Apnea Treatment Misses Primary Endpoint in Phase III Trial at TheStreet
06:09AM  RESMED INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
03:00AM  ResMed Provides Update on Phase III SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy In Central Sleep Apnea and Chronic Heart Failure PR Newswire
03:00AM  ResMed Provides Update on Phase III SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy In Central Sleep Apnea and Chronic Heart Failure CNW Group
May-05-15 10:00PM  Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD PR Newswire
May-01-15 08:11PM  10-Q for ResMed, Inc. at Company Spotlight
Apr-30-15 09:36AM  ResMed Introduces Lumis Series of Noninvasive Ventilators for Personalized, Simplified and Connected Care Other
09:00AM  ResMed Introduces Lumis Series of Noninvasive Ventilators for Personalized, Simplified and Connected Care PR Newswire
Apr-29-15 06:09AM  RESMED INC Files SEC form 10-Q, Quarterly Report
Apr-24-15 09:56AM  ResMed Beats Q3 Earnings by a Penny, Misses on Revenues - Analyst Blog Zacks -10.47%
Apr-23-15 06:10PM  ResMed beats 3Q profit forecasts AP
04:30PM  ResMed Inc Earnings Call scheduled for 4:30 pm ET today
04:29PM  ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 Other
04:07PM  RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and
04:05PM  ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 PR Newswire
07:07AM  Q3 2015 ResMed Inc Earnings Release - After Market Close
Apr-21-15 01:40PM  ResMed (RMD) Poised to Outshine Q3 Earnings Estimates - Analyst Blog Zacks
Apr-02-15 04:41PM  ResMed To Announce Third Quarter 2015 Results Other
04:30PM  ResMed To Announce Third Quarter 2015 Results PR Newswire
Mar-12-15 09:32AM  ResMed to Present New Data on Sleep-Disordered Breathing in Patients with Chronic Heart Failure at the American College of Cardiology 64th Annual Meeting at noodls
09:00AM  ResMed to Present New Data on Sleep-Disordered Breathing in Patients with Chronic Heart Failure at the American College of Cardiology 64th Annual Meeting PR Newswire
Mar-10-15 02:00PM  ResMed Makes It Big on Women's Day, Unveils SDB Device - Analyst Blog
Mar-06-15 06:27AM  ResMed Launches AirSense 10 AutoSet for Her: A Complete Integrated Sleep Solution for Europe's 1 in 5 Women Living with Sleep Apnoea PR Newswire
Feb-24-15 04:49PM  ResMed Upped to Hold on Several Growth Initiatives - Analyst Blog
Feb-16-15 09:17PM  Australian shares slip as Greek worries weigh
Feb-12-15 06:03PM  ResMed Wins Continued Injunction Against BMC in German Patent Infringement Action Other
05:30PM  ResMed Wins Continued Injunction Against BMC in German Patent Infringement Action PR Newswire
Feb-11-15 04:09PM  ResMed Targets Expansion in HME Market, Acquires Jaysec - Analyst Blog
Feb-10-15 08:30AM  ResMed Acquires Jaysec, a Leader in Internet-Based Software Solutions for Home Medical Equipment Providers PR Newswire
Feb-02-15 08:30AM  Easy-to-Use AirView Patient Management System by ResMed Now Integrates Directly with Brightree PR Newswire
Feb-01-15 07:07PM  10-Q for ResMed, Inc. Company Spotlight
Jan-30-15 06:02AM  RESMED INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Jan-26-15 09:00AM  ResMed (RMD) Beats Q2 Earnings & Revenues, Margin Falls - Analyst Blog Zacks
Jan-23-15 12:49PM  ResMed Stock Hits High As Growth Reignites at Investor's Business Daily +5.46%
11:18AM  ResMed (RMD) Stock Continues to Rise Today on Strong Quarterly Results at TheStreet
Jan-22-15 04:43PM  ResMed beats Street 2Q forecasts AP
04:30PM  ResMed Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:06PM  RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and EDGAR Online
04:05PM  ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 PR Newswire
07:07AM  Q2 2015 ResMed Inc Earnings Release - After Market Close CCBN
Jan-20-15 12:20PM  Will ResMed (RMD) Surprise Earnings Estimates in Q2? - Analyst Blog Zacks
Dec-23-14 06:24PM  ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical PR Newswire
Dec-18-14 04:30PM  ResMed To Announce Second Quarter 2015 Results PR Newswire
Dec-12-14 08:00AM  Zimmer Holdings Names Michael Farrell to Board of Directors PR Newswire
Dec-04-14 08:00AM  ResMed Unveils AirCurve 10 Series - Bringing More Therapy Choices to the ResMed Air Solutions Series PR Newswire
Nov-25-14 02:36PM  RESMED INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Nov-19-14 02:00PM  ResMed Strong on Q1 Results, Huge OSA Market Potential Zacks
Nov-18-14 08:00AM  ResMed's New S+ Consumer Sleep Monitor Now Integrates With Apple HealthKit PR Newswire
Nov-03-14 07:08PM  10-Q for ResMed, Inc. Company Spotlight
Oct-31-14 06:08AM  RESMED INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Oct-30-14 10:50AM  [$$] Nintendo Introducing Device to Improve Sleep at The Wall Street Journal
Oct-29-14 11:05PM  Nintendo to develop "quality of life" device to track sleep, fatigue - CEO Reuters
Oct-27-14 08:50AM  ResMed Posts In-Line Earnings on Revenue Beat in Q1 Zacks
06:37AM  Strength Seen in ResMed (RMD): Stock Gains 9.1% Zacks
Oct-24-14 03:00AM  Asia stocks mixed as Ebola, China concerns offset US gains at CNBC +9.06%
Oct-23-14 06:21PM  ResMed meets 1Q profit forecasts AP
04:30PM  ResMed Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:07PM  RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and EDGAR Online
04:05PM  RESMED Inc. Announces Results for the First Quarter of Fiscal Year 2015 PR Newswire
07:07AM  Q1 2015 ResMed Inc Earnings Release - After Market Close CCBN
Oct-21-14 08:30AM  ResMed myAir Patient Engagement Platform Supports and Coaches Patients to Improve Compliance PR Newswire
08:00AM  ResMed Enhances U-Sleep Patient Management Platform With Action View For Easier Management By Exception PR Newswire
Oct-20-14 08:00AM  ResMed Launches ResMed Data Exchange PR Newswire
Oct-10-14 02:20PM  Resmed Drops despite Launch of S+ Sleep Solution App Zacks
Oct-07-14 04:24PM  [video] The Best Sleep Tracking Gadgets at MarketWatch
08:00AM  ResMed Launches S+, the World's First Non-Contact System That Helps Consumers Measure, Analyze and Improve Their Sleep PR Newswire
Oct-02-14 04:30PM  ResMed To Announce First Quarter 2015 Results PR Newswire
ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders with a focus on sleep-disordered breathing (SDB). Its products include airflow generators, such as CPAP, VPAP and AutoSet systems for the titration and treatment of SBD; and masks, motors, and diagnostic products. The company also offers accessories and other products, such as humidifiers, carry bags, and breathing circuits, as well as data communications and control products, including EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. ResMed Inc. markets its products to sleep clinics, hospitals, home healthcare dealers, and third-party payers. The company sells its products through a network of distributors and direct sales force in approximately 100 countries internationally. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Farrell Michael J.Chief Executive OfficerAug 17Option Exercise15.525,97592,732128,415Aug 19 07:52 PM
Farrell Michael J.Chief Executive OfficerAug 17Sale55.545,975331,852122,440Aug 19 07:52 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Aug 03Option Exercise19.255,833112,28561,672Aug 05 02:52 PM
PENDARVIS DAVIDChief Administrative OfficerAug 03Option Exercise25.545,500140,47075,815Aug 05 05:11 PM
FARRELL PETER CChairman of the BoardAug 03Option Exercise19.2536,000693,000396,027Aug 05 05:12 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Aug 03Sale57.686,333365,29255,839Aug 05 02:52 PM
FARRELL PETER CChairman of the BoardAug 03Sale56.3436,0002,028,061360,027Aug 05 05:12 PM
PENDARVIS DAVIDChief Administrative OfficerAug 03Sale57.685,500317,24070,315Aug 05 05:11 PM
Farrell Michael J.Chief Executive OfficerJul 15Option Exercise15.525,97592,732128,415Jul 17 08:08 PM
Farrell Michael J.Chief Executive OfficerJul 15Sale57.595,975344,100122,440Jul 17 08:08 PM
PENDARVIS DAVIDChief Administrative OfficerJul 06Option Exercise25.545,500140,47075,815Jul 08 09:08 PM
PENDARVIS DAVIDChief Administrative OfficerJul 06Sale55.195,500303,54070,315Jul 08 09:08 PM
FARRELL PETER CChairman of the BoardJul 01Option Exercise19.2536,000693,000396,027Jul 06 08:25 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Jul 01Option Exercise19.255,833112,28562,172Jul 06 08:26 PM
FARRELL PETER CChairman of the BoardJul 01Sale55.6136,0002,001,854356,827Jul 06 08:25 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Jul 01Sale56.596,333358,37156,339Jul 06 08:26 PM
PENDARVIS DAVIDChief Administrative OfficerJun 03Option Exercise25.545,500140,47075,815Jun 05 07:50 PM
PENDARVIS DAVIDChief Administrative OfficerJun 03Sale59.415,500326,73570,315Jun 05 07:50 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Jun 01Option Exercise19.255,833112,28562,672Jun 03 06:41 PM
FARRELL PETER CChairman of the BoardJun 01Option Exercise19.2536,000693,000396,027Jun 03 06:43 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Jun 01Sale59.226,333375,01656,839Jun 03 06:41 PM
FARRELL PETER CChairman of the BoardJun 01Sale59.2536,0002,132,856360,027Jun 03 06:43 PM
Reiser AnnePresident - ResMed EMEA-APACMay 27Option Exercise17.303,00051,90071,120May 29 09:18 PM
Reiser AnnePresident - ResMed EMEA-APACMay 27Sale57.913,000173,72168,335May 29 09:18 PM
Farrell Michael J.Chief Executive OfficerMay 15Option Exercise15.525,97592,732128,415May 19 07:34 PM
Farrell Michael J.Chief Executive OfficerMay 15Sale56.625,975338,305122,440May 19 07:34 PM
PENDARVIS DAVIDChief Administrative OfficerMay 04Option Exercise25.545,500140,47075,815May 06 08:44 PM
PENDARVIS DAVIDChief Administrative OfficerMay 04Sale65.105,500358,05070,315May 06 08:44 PM
Douglas Robert AndrewPresident and COO ResMed Inc.May 01Option Exercise19.255,833112,28563,172May 05 05:54 PM
FARRELL PETER CChairman of the BoardMay 01Option Exercise19.2536,000693,000404,599May 05 08:23 PM
FARRELL PETER CChairman of the BoardMay 01Sale64.5636,0002,324,232368,599May 05 08:23 PM
Douglas Robert AndrewPresident and COO ResMed Inc.May 01Sale63.926,333404,80557,339May 05 05:54 PM
Farrell Michael J.Chief Executive OfficerApr 15Option Exercise15.525,97592,732128,331Apr 17 12:08 PM
Farrell Michael J.Chief Executive OfficerApr 15Sale73.245,975437,609122,356Apr 17 12:08 PM
PENDARVIS DAVIDChief Administrative OfficerApr 06Option Exercise25.545,500140,47075,591Apr 08 06:19 PM
Reiser AnnePresident - ResMed EuropeApr 06Option Exercise17.303,00051,90071,120Apr 08 06:20 PM
Reiser AnnePresident - ResMed EuropeApr 06Sale73.953,000221,85068,120Apr 08 06:20 PM
PENDARVIS DAVIDChief Administrative OfficerApr 06Sale72.605,500399,30070,091Apr 08 06:19 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Apr 01Option Exercise19.255,833112,28563,503Apr 03 06:57 PM
FARRELL PETER CChairman of the BoardApr 01Option Exercise17.9238,000680,932391,042Apr 03 07:01 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Apr 01Sale70.676,333447,55657,620Apr 03 06:57 PM
FARRELL PETER CChairman of the BoardApr 01Sale70.7036,0002,545,049368,599Apr 03 07:01 PM
Reiser AnnePresident - ResMed EuropeMar 18Option Exercise17.304,00069,20072,120Mar 20 08:12 PM
Reiser AnnePresident - ResMed EuropeMar 18Sale71.454,000285,80068,120Mar 20 08:12 PM
Reiser AnnePresident - ResMed EuropeMar 16Option Exercise17.304,00069,20072,120Mar 18 08:09 PM
Farrell Michael J.Chief Executive OfficerMar 16Option Exercise15.835,97594,579128,031Mar 18 08:10 PM
Reiser AnnePresident - ResMed EuropeMar 16Sale69.104,000276,40068,120Mar 18 08:09 PM
Farrell Michael J.Chief Executive OfficerMar 16Sale69.105,975412,873122,356Mar 18 08:10 PM
Reiser AnnePresident - ResMed EuropeMar 09Option Exercise17.303,00051,90065,198Mar 11 02:26 PM
Reiser AnnePresident - ResMed EuropeMar 09Sale66.753,000200,25062,198Mar 11 02:26 PM
PENDARVIS DAVIDChief Administrative OfficerMar 03Option Exercise25.545,500140,47075,591Mar 05 08:06 PM
PENDARVIS DAVIDChief Administrative OfficerMar 03Sale64.385,500354,06870,091Mar 05 08:06 PM
FARRELL PETER CChairman of the BoardMar 02Option Exercise15.5236,000558,720203,864Mar 04 08:25 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Mar 02Option Exercise64.385,833375,54058,120Mar 04 08:25 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Mar 02Sale64.396,333407,75058,120Mar 04 08:25 PM
FARRELL PETER CChairman of the BoardMar 02Sale64.6436,0002,326,860167,864Mar 04 08:25 PM
ROBERTS CHRISTOPHER GDirectorFeb 20Sale65.6810,000656,769259,400Feb 24 08:49 PM
Reiser AnnePresident - ResMed EuropeFeb 17Option Exercise17.305,00086,50067,198Feb 19 12:10 PM
Reiser AnnePresident - ResMed EuropeFeb 17Sale66.115,000330,52562,198Feb 19 12:10 PM
Sandercock BrettChief Financial OfficerFeb 13Option Exercise15.52100,0001,552,000160,913Feb 17 07:54 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 05Sale62.355,500342,92570,091Feb 05 06:41 PM
WAREHAM JOHN PDirectorFeb 04Option Exercise25.5436,000919,44049,000Feb 06 08:05 PM
ROBERTS CHRISTOPHER GDirectorFeb 04Option Exercise19.4079,5001,541,955183,930Feb 06 08:04 PM
SULPIZIO RICHARDDirectorFeb 04Option Exercise18.0172,0001,296,612108,387Feb 06 04:51 PM
SULPIZIO RICHARDDirectorFeb 04Sale63.1572,0004,546,58436,387Feb 06 04:51 PM
WAREHAM JOHN PDirectorFeb 04Sale63.4936,0002,285,60413,000Feb 06 08:05 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 03Option Exercise25.545,500140,47075,591Feb 05 06:41 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Feb 03Option Exercise19.255,833112,28564,453Feb 05 08:13 PM
Sandercock BrettChief Financial OfficerFeb 03Sale62.8218,6701,172,85160,913Feb 05 08:15 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Feb 03Sale62.356,333394,86358,620Feb 05 08:13 PM
FARRELL PETER CChairman of the BoardFeb 02Option Exercise15.5236,000558,720203,864Feb 04 08:36 PM
FARRELL PETER CChairman of the BoardFeb 02Sale61.9736,0002,230,774167,864Feb 04 08:36 PM
PACE GARY WDirectorJan 26Option Exercise16.5048,000791,904141,158Jan 28 08:24 PM
TAYLOR RONALD RDirectorJan 26Option Exercise15.5236,000558,72071,471Jan 28 08:25 PM
PACE GARY WDirectorJan 26Sale66.7748,0003,204,81693,158Jan 28 08:24 PM
TAYLOR RONALD RDirectorJan 26Sale66.9836,0002,411,31635,471Jan 28 08:25 PM
PENDARVIS DAVIDChief Administrative OfficerJan 05Option Exercise25.545,500140,47075,591Jan 06 02:29 PM
PENDARVIS DAVIDChief Administrative OfficerJan 05Sale57.095,500313,98770,091Jan 06 02:29 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Jan 02Option Exercise18.677,500140,02566,124Jan 06 01:52 PM
FARRELL PETER CChairman of the BoardJan 02Option Exercise15.5236,000558,720203,864Jan 06 12:41 PM
FARRELL PETER CChairman of the BoardJan 02Sale56.9936,0002,051,640167,864Jan 06 12:41 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Jan 02Sale56.998,000455,92558,624Jan 06 01:52 PM
FARRELL PETER CChairman of the BoardDec 01Option Exercise15.5236,000558,720292,375Dec 03 09:09 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Dec 01Option Exercise18.677,500140,02566,624Dec 03 09:11 PM
FARRELL PETER CChairman of the BoardDec 01Sale53.2836,0001,918,188256,375Dec 03 09:09 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Dec 01Sale52.938,000423,44059,124Dec 03 09:11 PM
Sandercock BrettChief Financial OfficerNov 25Sale51.1515,000767,25079,583Dec 01 09:08 PM
FARRELL PETER CChairman of the BoardNov 18Option Exercise15.5236,000558,720292,375Nov 20 09:24 PM
FARRELL PETER CChairman of the BoardNov 18Sale52.3936,0001,886,148256,375Nov 20 09:24 PM
Hollingshead JamesPresident, AmericasNov 11Option Exercise51.1522,9031,171,48862,639Nov 13 08:56 PM
PENDARVIS DAVIDChief Administrative OfficerNov 11Option Exercise33.702,96799,98878,417Nov 13 06:38 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Nov 03Option Exercise17.627,500132,15049,797Nov 05 09:02 PM
PENDARVIS DAVIDChief Administrative OfficerNov 03Option Exercise15.523,55755,20579,007Nov 05 08:54 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Nov 03Sale51.848,000414,75544,297Nov 05 09:02 PM
PENDARVIS DAVIDChief Administrative OfficerNov 03Sale52.003,557184,96475,450Nov 05 08:54 PM
FARRELL PETER CChairman of the BoardOct 29Option Exercise12.47119,2041,486,235400,468Oct 31 07:46 PM
FARRELL PETER CChairman of the BoardOct 29Sale51.84119,2046,179,416281,264Oct 31 07:46 PM
Farrell Michael J.Chief Executive OfficerOct 15Option Exercise21.683,20069,360147,047Oct 17 08:42 PM
Farrell Michael J.Chief Executive OfficerOct 15Sale46.613,200149,158143,847Oct 17 08:42 PM
PENDARVIS DAVIDChief Administrative OfficerOct 03Option Exercise15.525,00077,60080,206Oct 06 08:27 PM